Insmed's Q4 Loss Wider Than Expected, Sales In Line With Estimates

Insmed (INSM) reported a fourth-quarter 2024 loss of $1.32 per share, wider than the Zacks Consensus Estimate of a loss of$1.15. In the year-ago quarter, the company posted a loss of $1.28 per share.Insmed generated total quarterly revenues of$104.4 million, which rose 25% year over year. Quarterly sales were in line with the Zacks Consensus Estimate.See the Zacks Earnings Calendar to stay ahead of market-making news.Shares of INSM were down more than 4% in after-market trading on Thursday likely due to t ...